Many are called MDS cell lines: one is chosen

Area of Science:

• Hematology
• Cancer Biology
• Cell Line Research

Background:

• Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders with genetic instability, often progressing to acute myeloid leukemia (AML).
• Leukemia cell lines are crucial for understanding hematological malignancies, but their authenticity requires rigorous validation.
• Previous characterization revealed cross-contamination in a significant minority of purported MDS cell lines.

Purpose of the Study:

• To critically evaluate and categorize 31 cell lines described as originating from patients with myelodysplastic syndromes (MDS).
• To differentiate between cell lines established during the MDS phase versus the leukemic AML/MDS phase.
• To assess the utility and distinct characteristics of MDS and AML/MDS cell lines in research.

Main Methods:

• DNA profiling to identify cross-contaminated cell lines.
• Literature review and data analysis to categorize cell lines based on their origin (MDS phase, AML/MDS phase, or false).
• Comparative assessment of cell line characteristics and research applications.

Main Results:

• Categorization of 31 candidate MDS cell lines into three groups: false/non-malignant, established in the AML/MDS phase, and established in the MDS phase.
• Identification of cross-contamination in a significant number of previously reported MDS cell lines.
• Demonstration that most "authentic" MDS cell lines were derived from the leukemic phase.

Conclusions:

• MDS and AML/MDS cell lines represent distinct biological entities and should be considered separately in research.
• Authentic MDS cell lines, particularly those from the MDS phase, are rare but valuable resources.
• Accurate cell line characterization is essential for reliable modeling of hematological malignancies and drug development.